These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate. Suh DY, Boden SD, Louis-Ugbo J, Mayr M, Murakami H, Kim HS, Minamide A, Hutton WC. Spine (Phila Pa 1976); 2002 Feb 15; 27(4):353-60. PubMed ID: 11840099 [Abstract] [Full Text] [Related]
4. Experimental spinal fusion using sintered bovine bone coated with type I collagen and recombinant human bone morphogenetic protein-2. Minamide A, Tamaki T, Kawakami M, Hashizume H, Yoshida M, Sakata R. Spine (Phila Pa 1976); 1999 Sep 15; 24(18):1863-70; discussion 1871-2. PubMed ID: 10515009 [Abstract] [Full Text] [Related]
5. Ne-Osteo bone growth factor for posterolateral lumbar spine fusion: results from a nonhuman primate study and a prospective human clinical pilot study. Boden SD, Grob D, Damien C. Spine (Phila Pa 1976); 2004 Mar 01; 29(5):504-14. PubMed ID: 15129063 [Abstract] [Full Text] [Related]
6. Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate. Boden SD, Martin GJ, Morone MA, Ugbo JL, Moskovitz PA. Spine (Phila Pa 1976); 1999 Jun 15; 24(12):1179-85. PubMed ID: 10382242 [Abstract] [Full Text] [Related]
7. Evidence of osteoinduction by Grafton demineralized bone matrix in nonhuman primate spinal fusion. Louis-Ugbo J, Murakami H, Kim HS, Minamide A, Boden SD. Spine (Phila Pa 1976); 2004 Feb 15; 29(4):360-6; discussion Z1. PubMed ID: 15094531 [Abstract] [Full Text] [Related]
8. 1995 Volvo Award in basic sciences. The use of an osteoinductive growth factor for lumbar spinal fusion. Part II: Study of dose, carrier, and species. Boden SD, Schimandle JH, Hutton WC. Spine (Phila Pa 1976); 1995 Dec 15; 20(24):2633-44. PubMed ID: 8747241 [Abstract] [Full Text] [Related]
9. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion. Akamaru T, Suh D, Boden SD, Kim HS, Minamide A, Louis-Ugbo J. Spine (Phila Pa 1976); 2003 Mar 01; 28(5):429-34. PubMed ID: 12616152 [Abstract] [Full Text] [Related]
10. Early-term and mid-term histologic events during single-level posterolateral intertransverse process fusion with rhBMP-2/collagen carrier and a ceramic bulking agent in a nonhuman primate model: implications for bone graft preparation. Khan SN, Toth JM, Gupta K, Glassman SD, Gupta MC. J Spinal Disord Tech; 2014 Jun 01; 27(4):212-9. PubMed ID: 23073151 [Abstract] [Full Text] [Related]
11. Evaluation of carriers of bone morphogenetic protein for spinal fusion. Minamide A, Kawakami M, Hashizume H, Sakata R, Tamaki T. Spine (Phila Pa 1976); 2001 Apr 15; 26(8):933-9. PubMed ID: 11317116 [Abstract] [Full Text] [Related]
12. Comparison of Healos/bone marrow to INFUSE(rhBMP-2/ACS) with a collagen-ceramic sponge bulking agent as graft substitutes for lumbar spine fusion. Kraiwattanapong C, Boden SD, Louis-Ugbo J, Attallah E, Barnes B, Hutton WC. Spine (Phila Pa 1976); 2005 May 01; 30(9):1001-7; discussion 1007. PubMed ID: 15864149 [Abstract] [Full Text] [Related]
13. Experimental spinal fusion with recombinant human bone morphogenetic protein-2. Schimandle JH, Boden SD, Hutton WC. Spine (Phila Pa 1976); 1995 Jun 15; 20(12):1326-37. PubMed ID: 7676329 [Abstract] [Full Text] [Related]
14. Lower dose of rhBMP-2 achieves spine fusion when combined with an osteoconductive bulking agent in non-human primates. Barnes B, Boden SD, Louis-Ugbo J, Tomak PR, Park JS, Park MS, Minamide A. Spine (Phila Pa 1976); 2005 May 15; 30(10):1127-33. PubMed ID: 15897825 [Abstract] [Full Text] [Related]
15. The efficacy of a nanosynthetic bone graft substitute as a bone graft extender in rabbit posterolateral fusion. Conway JC, Oliver RA, Wang T, Wills DJ, Herbert J, Buckland T, Walsh WR, Gibson IR. Spine J; 2021 Nov 15; 21(11):1925-1937. PubMed ID: 34033931 [Abstract] [Full Text] [Related]
16. Evaluation of a new formulation of demineralized bone matrix putty in a rabbit posterolateral spinal fusion model. Kiely PD, Brecevich AT, Taher F, Nguyen JT, Cammisa FP, Abjornson C. Spine J; 2014 Sep 01; 14(9):2155-63. PubMed ID: 24512696 [Abstract] [Full Text] [Related]
17. The use of cultured bone marrow cells in type I collagen gel and porous hydroxyapatite for posterolateral lumbar spine fusion. Minamide A, Yoshida M, Kawakami M, Yamasaki S, Kojima H, Hashizume H, Boden SD. Spine (Phila Pa 1976); 2005 May 15; 30(10):1134-8. PubMed ID: 15897826 [Abstract] [Full Text] [Related]
18. The effects of bone morphogenetic protein and basic fibroblast growth factor on cultured mesenchymal stem cells for spine fusion. Minamide A, Yoshida M, Kawakami M, Okada M, Enyo Y, Hashizume H, Boden SD. Spine (Phila Pa 1976); 2007 May 01; 32(10):1067-71. PubMed ID: 17471086 [Abstract] [Full Text] [Related]
19. Lumbar spinal fusion with a mineralized collagen matrix and rhBMP-2 in a rabbit model. Liao SS, Guan K, Cui FZ, Shi SS, Sun TS. Spine (Phila Pa 1976); 2003 Sep 01; 28(17):1954-60. PubMed ID: 12973141 [Abstract] [Full Text] [Related]